NEW YORK, Feb. 5, 2026 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Danone S.A. (“Danone” or the “Company”) (OTCMKTS: DANOY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
The investigation concerns whether Danone and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On January 21, 2026, Reuters reported Danone was “recalling and blocking batches of infant milk formula after a contamination scare.” Specifically, cereulide, a potent cytotoxin, had been detected in Danone’s Thai-origin Dumex Dulac 1.
On this news, Danone’s American Depositary Receipt (“ADR”) price fell $1.37 per ADR, or 7.95%, to close at $15.87 per ADR on January 21, 2026.
Then, on January 23, 2026, Danone issued a press release announcing a recall of select batches of its infant formula “to comply with the latest guidance.”
On this news, Danone’s ADR price fell $0.43 per ADR, or 2.7%, to close at $15.55 per ADR on January 23, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
SOURCE Pomerantz LLP
